ScPharmaceuticals Inc. (SCPH)
Delisted
7 Oct 2025
NASDAQ (NGS) NASDAQ (NGS) Primary $
5. 67
0
0%
$
302.2M Market Cap
- P/E Ratio
- Div Yield
10.9M Volume
-1.49 Eps
$ 5.67
Previous Close Day Range
5.67 5.67
Year Range
1.94 6.28
Want to track SCPH and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
scPharmaceuticals Inc. (SCPH) Q2 2024 Earnings Call Transcript
scPharmaceuticals Inc. (NASDAQ:SCPH ) Q2 2024 Earnings Call Transcript August 14, 2024 4:30 PM ET Company Participants PJ Kelleher - IR John Tucker - CEO Steve Parsons - SVP, Commercial Rachael Nokes - CFO Conference Call Participants Roanna Ruiz - Leerink Partners Chase Knickerbocker - Craig-Hallum Capital Group Operator Greetings, and welcome to the scPharmaceuticals Second Quarter 2024 Earnings Conference Call. At this time all participants are in a listen-only mode.
Seekingalpha | 2 years ago
ScPharmaceuticals, Inc. (SCPH) Reports Q2 Loss, Tops Revenue Estimates
ScPharmaceuticals, Inc. (SCPH) came out with a quarterly loss of $0.44 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.36 per share a year ago.
Zacks | 2 years ago
